tesamorelin ipamorelin blend 8mg 2mg and (6mg / 2mg) Ipamorelin blend is Synthesized and Lyophilized in the USA. Tesamorelin Ipamorelin 6/2 mg |

The Future: FDA Approved Peptides 2026 & Beyond Late-Stage Pipeline (Expected Decisions 2025-2026) The following peptide therapeutics are undergoing FDA review or Phase 3 trials with potential 2026 approvals: Retatrutide (Eli Lilly) the retatrutide approval status 2026 covers this Triple G (GIP/GLP-1/Glucagon) receptor agonist for obesity Cagrilintide + Semaglutide (CagriSema) the cagrilintide FDA approval status tracks this Novo Nordisk combination therapy for obesity Survodutide The survodutide FDA approval status 2026 shows this dual glucagon/GLP-1 receptor agonist (Zealand/Boehringer Ingelheim) is in Phase 3 trials for obesity and MASH (metabolic dysfunction-associated steatohepatitis)

[DOI] [PMC free article] [PubMed] [Google Scholar] Rosario LA, OBrien ML, Henderson CJ, Wolf CR and Tew KD

GHK-Cu regulates pathways involving glutathione metabolism, NF-B signaling, and mitochondrial protection

Ghrelin up-regulates cartilage-specific genes via the ERK/STAT3 pathway in chondrocytes of patients with adolescent idiopathic scoliosis

These treatments address a wide variety of health conditions that result from poor immune system health

ZMT (6 capsules nightly) Combines zinc, magnesium, ashwagandha, and other adaptogens to promote deep sleep, testosterone production, and cortisol regulation